Based in St. Jean (Toulouse), France, Tesalys is a French manufacturer of equipment for the treatment of infectious waste on site. Toulouse, a global showcase of European industrial know-how, has brought Tesalys the elements necessary for the international development of its STERIPLUSTM technology. With the STERIPLUSTM crusher-sterilizer, Tesalys has quickly become a leader in bio-contaminated waste treatment systems on the production site. Tesalys is now present through a network of distributors in more than 90 countries on five continents..
Management team :
Miquel Lozano President Founding partner Sales and Marketing
Jean-Michel Rodriguez Managing Director Founding Partner Operations, Administration and Finances
Emmanuel Hengl Technical Director Founding Partner R&D, Technical
TESALYS was supported in its development for the 2014-2017 period by the Occitanie Pyrénées-Méditerranée Region and the FEDER (European Regional Development Fund).
Tesalys benefited from the PassExport and Export Contracts of the Occitania region for carrying out international development actions.
TESALYS also benefited from Innovation and Seed Loans as well as Export Prospecting Insurance, BPIFRANCE devices This financial support made it possible to intensify R & amp; D and IP efforts, recruit technical and commercial staff and carry out marketing and communication actions, in particular internationally.
Associations and other links of interest
1992 Patrick Hengl and Miquel Lozano met for the first time Exchanges regarding biohazardous waste treatment solutions
2012 Tesalys was set up STERIPLUS™ 20 was developed
2013 STERIPLUS™ 40 was developed Tesalys won the Midinvest 2013 award First sales
2014 Tesalys relocated to new premises in St. Jean (Toulouse) Round of financing – Equity investment by Entrepreneur Venture
2015 Jury’s prize at the Inn’Ovations 2015 awards Approval in France by the Ministry of Health and the Ministry of Ecology and Sustainable Development (NF X 30-503) Sales in around twenty countries
2016 Marco Polo prize EY’s prize for entrepreneur of the year STERIPLUSTM 80 was developed TESALYS continues its development through an external growth operation with the acquisition of Sterishred
2017 Development of sales of the STERISHRED® 250 model Business growth in Southeast Asia
2018 Fundraising (series B) – Entry into the capital of IXO PE and Sigma Gestion Retirement of one of the founding partners, Patrick Hengl
2019 Investment in a new 1,500 m2 production unit in St. Jean (Toulouse) “Export Category” winner of the CEO’s Business Challenges Trophy Delivery of the first units of the STERISHRED® 700 model
2020 Relocation of all production to sites in the Toulouse region. Tesalys joins French Healthcare
global presence in 70+ countries
8 YEARS of R & D
30 min to inactivate your wastes
8log10 MICROBIOLOGICAL EFFECTIVENESS